ASX Share rice
Wed 05 Aug 2020 - 12:07:am (Sydney)

RAC Share Price

RACE ONCOLOGY LTDRACPharmaceuticals, Biotechnology & Life Sciences

RAC Company Information


Race Oncology Limited





GIC Industry:


GIC Sub Industry:



140 William Street Melbourne VIC Australia 3000


61 3 9097 1656

Exec. Chairman:

Dr. John Cullity

COO & Non-Exec. Director:

Dr. Daniel Tillett

Company Sec.:

Mr. Peter Gordon Webse M.A.I.C.D., B.Bus, FGIA, FCIS, FCPA, MAICD

Company Overview:

Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Melbourne, Australia.

RAC Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


RAC CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


RAC Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


RAC Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:




Total Current Liabilities:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


RAC Share Price History

RAC News

22 Nov, 2019
It is a pleasure to report that the Race Oncology Limited (ASX:RAC) is up 47% in the last quarter. But that doesn't...